Catamaran Completes Acquisition of RESTAT
SCHAUMBURG, Ill., October 1, 2013 – Catamaran Corp. (NASDAQ: CTRX, TSX: CCT), a leading
provider of pharmacy benefit management (PBM) services and technology, announced today the
completion, effective as of October 1, 2013, of its previously disclosed acquisition of RESTAT, LLC
(“RESTAT”), for a purchase price of $409.5 million in cash, subject to certain customary post-closing
adjustments. The purchase price was funded from Catamaran’s existing cash balance and $350 million
in borrowings under its revolving credit facility.
“This is yet one more step to executing on our strategy of pursuing acquisitions in the middle market,”
said Mark Thierer, Chairman and CEO of Catamaran. “RESTAT presents a great opportunity to add to
our scale and to offer new programs and services to RESTAT clients.”
RESTAT provides prescription claim processing and PBM services. RESTAT is based in Milwaukee,
Wisconsin, where its operations will remain.
About Catamaran
Catamaran, one of the industry's fastest-growing pharmacy benefits manager, helps organizations and
the communities they serve take control of prescription drug costs. Managing more than 250 million
prescriptions each year on behalf of 25 million members, our flexible, holistic solutions improve patient
care and empower individuals to take charge of their health. Processing one in every five prescription
claims in the U.S., Catamaran's skill and scale deliver compelling financial results and sustainable
improvement in the overall health of members. Catamaran is headquartered in Schaumburg, Illinois with
multiple locations in the U.S. and Canada. For more information, please visit CatamaranRx.com.
For further information contact:
Tony Perkins
Investor Relations
Catamaran Corporation
Tel: (312) 261-7805
Tony.Perkins@catamaranRx.com
Forward Looking Statements
Certain information included herein constitutes “forward-looking statements” within the meaning of
applicable securities laws and is subject to important risks, uncertainties and assumptions. These
forward-looking statements include, among other things, information with respect to the Company's
anticipated operating results and management's objectives and the strategies to achieve those objectives,
as well as information with respect to the Company's beliefs, plans, expectations, anticipations, estimates
and intentions. Forward-looking statements are necessarily based upon a number of estimates and
assumptions that, while considered reasonable by management at this time, are inherently subject to
significant business, economic and competitive uncertainties and contingencies. We caution that such
forward-looking statements involve known and unknown risks, uncertainties and other risks that may
cause our actual financial results, performance, or achievements to be materially different from our
estimated future results, performance or achievements expressed or implied by those forward-looking
statements. Numerous factors could cause actual results to differ materially from those in the forward
looking statements, including without limitation, the risks and challenges associated with our PBM
partnering agreement with Cigna Corporation due to the size of the client and the complexity and term of
the agreement; our dependence on, and ability to retain, key customers; our ability to achieve increased
market acceptance for our product offerings and penetrate new markets; consolidation in the healthcare
industry; the existence of undetected errors or similar problems in our software products; our ability to
identify and complete acquisitions, manage our growth, integrate acquisitions and achieve expected
synergies from acquisitions; our ability to compete successfully; potential liability for the use of incorrect or
incomplete data; the length of the sales cycle for our solutions and services; interruption of our operations
due to outside sources; maintaining our intellectual property rights and litigation involving intellectual
property rights; our ability to obtain, use or successfully integrate third-party licensed technology;
compliance with existing laws, regulations and industry initiatives and future changes in laws or
regulations in the healthcare industry; breach of our security by third parties; our dependence on the
expertise of our key personnel; our access to sufficient capital to fund our future requirements; potential
write-offs of goodwill or other intangible assets; and the outcome of any legal proceeding that has been or
may be instituted against us.
In addition, numerous factors could cause actual results with respect to the RESTAT acquisition to differ
materially from those in the forward-looking statements, including, without limitation, the possibility that
the expected efficiencies and cost savings from the transaction will not be realized, or will not be realized
within the expected time period; the risk that the Catamaran and RESTAT businesses will not be
integrated successfully; disruption from the transaction making it more difficult to maintain business and
operational relationships; and the risk of customer attrition at RESTAT or Catamaran. This list is not
exhaustive of the factors that may affect any of our forward-looking statements and is subject to change.
Other factors that should be considered are discussed from time to time in Catamaran's filings with the
U.S. Securities and Exchange Commission, including the risks and uncertainties discussed under the
captions “Risk Factors” and “Management's Discussion and Analysis of Financial Condition and Results
of Operations” in our Annual Report on Form 10-K and subsequent Form 10-Qs, which are available at
www.sec.gov. Investors are cautioned not to put undue reliance on forward-looking statements. All
subsequent written and oral forward-looking statements attributable to Catamaran or persons acting on
our behalf are expressly qualified in their entirety by this notice. We disclaim any intent or obligation to
update publicly these forward-looking statements, whether as a result of new information, future events or
otherwise.
THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS RELEASE REPRESENTS THE
COMPANY'S CURRENT EXPECTATIONS AND, ACCORDINGLY, IS SUBJECT TO CHANGE.
HOWEVER, THE COMPANY EXPRESSLY DISCLAIMS ANY INTENTION OR OBLIGATION TO
UPDATE OR REVISE ANY FORWARD-LOOKING INFORMATION, WHETHER AS A RESULT OF NEW
INFORMATION, FUTURE EVENTS OR OTHERWISE, EXCEPT AS REQUIRED BY APPLICABLE LAW.
